{
    "sec_cik": "0000875320",
    "sec_company_name": "VERTEX PHARMACEUTICALS INC / MA (Filer)",
    "document_type": "10K",
    "sec_form_header": "Form 10-K",
    "sec_period_of_report": "20211231",
    "sec_filing_date": "20220209",
    "sec_changed_date": "20220209",
    "sec_accepted_date": "20220209163744",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/875320/000087532022000007/0000875320-22-000007.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0013\003\VRTX_0000875320_10K_20211231_Item7_metadata.json",
    "original_file_name": "",
    "original_file_size": "3111753 chars",
    "document_group": "10-K",
    "section_name": "Item7",
    "section_n_characters": 54911,
    "endpoints": [
        "ITEM 7.MANAGEMENTâ€™S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
        "ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK"
    ],
    "extraction_method": "xbrl",
    "warnings": [],
    "company_description": "VRTX",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0013\003\VRTX_0000875320_10K_20211231_Item7_excerpt.txt",
    "time_elapsed": 0.4,
    "batch_number": 13,
    "batch_signature": "",
    "batch_start_time": "2023-04-27 17:30:01.551160",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-27 17:50:33.610738"
}